The 1991 Elis Berven Lecture: Radiotherapy in the Nineties: Increase in cure, decrease in morbidity

References

• Turesson I, Thames H D. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation and telangiectasia after 3 and 5 years follow-up. Radiother Oncol 1989; 15: 169–88
   PubMed Web of Science ®Google Scholar
• Berglund G, Bolund C, Fornander T, Rutqvist L E, Sjöden P-O. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 1991; 27: 1075–81
   PubMed Web of Science ®Google Scholar
• Dische S, Warburton M F, Jones D, Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol 1989; 16: 103–8
   PubMedGoogle Scholar
• Barendsen E W. Radiobiology of neutrons. Int J Radiat Oncol Biol Phys 1982; 8: 103–8
   Google Scholar
• Fowler J F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679–94
   PubMed Web of Science ®Google Scholar
• Withers H R, Taylor J MG, Macieiewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46
   PubMed Web of Science ®Google Scholar
• Edsmyr F, Anderson L, Esposti P L, Littbrand B, Nilsson B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 1985; 4: 197–203
   Google Scholar
• Parsons J T, Cassisi N J, Million R R. Results of twice–a-day irradiation of squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 1984; 10: 2041–51
   PubMed Web of Science ®Google Scholar
• Horiot J C, Le Fur R, N'Guyen T, et al. Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. Eur J Cancer 1990; 26: 119–80
   Google Scholar
• Cox J D, Pajak T F, Marcial V A, et al. ASTRO Plenary: Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group Protocol 8313. Int J Radiat Oncol Biol Phys 1991; 20: 1191–5
   PubMed Web of Science ®Google Scholar
• Dische S, Martin W MC, Anderson P. Radiation myelopathy in patients treated for carcinoma of bronchus using a six fraction regime of radiotherapy. Br J Radiol 1981; 54: 29–35
   PubMed Web of Science ®Google Scholar
• Hatlevoll R, Høst H, Kaalhus O. Myelopathy following radiotherapy of bronchial carcinoma with large single fractions: A retrospective study. Int J Radiat Oncol Biol Phys 1983; 9: 41–4
   PubMedGoogle Scholar
• Henk J M, James K W. Comparative trial of large and small fractions in the radiotherapy of head and neck cancers. Clin Radiol 1978; 29: 611–6
   PubMed Web of Science ®Google Scholar
• Weissberg J B, Son Y H, Percarpio B, Fischer J J. Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1982; 8: 179–85
   PubMed Web of Science ®Google Scholar
• Rezvani M, Alcock T J, Fowler J F, Haybittle J L, Hopewell L W, Wiernik G. A comparison of the normal tissue reactions in patients treated with either 3F/wk or 5F/wk in the BIR (British Institute of Radiology) trial of radiotherapy for carcinoma of the laryngopharynx. Int J Radiat Biol 1989; 56: 717–20
   PubMed Web of Science ®Google Scholar
• Wiernik G, Bates T D, Bleehen N M, et al. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol 1990; 63: 169–80
   PubMed Web of Science ®Google Scholar
• Leslie M D, Dische S. Parotid gland function following accelerated and conventionally fractionated radiotherapy. Radio–ther Oncol 1991; 22: 133–9
   PubMed Web of Science ®Google Scholar
• Lartigau E, Saunders M I, Dische S, Warburton M F, Des Rochers C. A comparison of the late radiation changes after three schedules of radiotherapy. Radiother Oncol 1991; 20: 139–48
   PubMed Web of Science ®Google Scholar
• Morris W J, Dische S, Mott G. A pilot study of a method of estimating the number of functional eccrine sweat glands in irradiated human skin. Radiother Oncol, (In press)
   Google Scholar
• Maciejewski B, Zajusz A, Pilecki B, et al. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer. Radiother Oncol 1991; 23: 7–11
   Google Scholar
• Abdelaal A S, Barker D S, Fergusson M M. Treatment for irradiation-induced mucositis. Lancet 1989; 1: 97
   PubMedGoogle Scholar
• Guyen N TD, Demange L, Froissart D, Panis X, Loirette M. Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck. Cancer 1985; 56: 16–9
   PubMedGoogle Scholar
• Dische S, Saunders M I. Continuous, hyperfractionated, accelerated radiotherapy (CHART). An interim report upon late morbidity. Radiother Oncol 1989; 16: 67–74
   Google Scholar
• Joiner M, Johns H, Stevens G. Modification of late renal injury by pentoxifylline. 1990; 51–2, Gray Laboratory Cancer Research Campaign Annual Report
   Google Scholar
• Saunders M I, Dische S, Grosch E J, et al. Experience with CHART. Int J Radiat Oncol Biol Phys 1991; 21: 871–8
   PubMed Web of Science ®Google Scholar
• Saunders M I. Is control of the primary tumour worthwhile in non-small cell carcinoma of the bronchus?. Clin Oncol 1991; 3: 185–8
   Google Scholar
• Saunders M I, Dische S. Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1990; 19: 1211–5
   PubMed Web of Science ®Google Scholar
• Suit H. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 1982; 50: 1227–34
   PubMed Web of Science ®Google Scholar
• Brock W A, Baker F L. Wike JL, Sivon SL, Peters LJ. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys 1990; 18: 1283–6
   PubMed Web of Science ®Google Scholar
• West C ML, Davidson S E, Hunter R D. Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int J Radiat Biol 1989; 56: 761–5
   PubMed Web of Science ®Google Scholar
• Dische S. A review of hypoxic cell radiosensitization. Int J Radiat Oncol Biol Phys 1991; 20: 147–52
   PubMed Web of Science ®Google Scholar
• Medical Research Council. A trial of Ro 03 8799 (pimonidazole) in carcinoma of the uterine cervix. A report from the Medical Research Council Working Party on Advanced Carcinoma of the Cervix. Radiother Oncol, (In press)
   Google Scholar
• Dische S, Rojas A, Rugg T, Hong A, Michael B D. Carbogen breathing: a system for use in man. Br J Radiol 1992; 65: 87–90
   PubMed Web of Science ®Google Scholar
• Rojas A. Radiosensitization with normobaric oxygen and carbogen. Radiother Oncol 1991; 65–70, (Suppl 20)
   PubMedGoogle Scholar
• Rojas A, Denekamp J, Joiner M C. ARCON: Accelerated radiotherapy with carbogen and nicotinamide. Bioreductive drugs, oxygen and radiotherapy, W Dobrowsky, Vienna, (In press.)
   Google Scholar
• Adams G E, Stratford I J. Hypoxia-selective bioreductive drugs. Oxford textbook of oncology, M Peckham, R Pinedo, U Veronesi. Oxford University Press, Oxford, (In press.)
   Google Scholar
• Begg A C, McNally N J, Shrieve D C, Karcher H A. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–6
   PubMedGoogle Scholar
• Wilson G D, McNally N J, Dische S, et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988; 58: 423–31
   PubMed Web of Science ®Google Scholar
• Bennett M H, Wilson G D, Dische S, Saunders M I, Martindale C A, O'Halloran A. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 1992; 65: 870–8
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Preuss-Bayer G, Trott K-R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321–8
   PubMed Web of Science ®Google Scholar
• Taylor J MG, Withers H R, Mendenhall W M. Dose–time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990; 17: 95–102
   PubMed Web of Science ®Google Scholar
• Hliniak A, Maciejewski B, Trott K-R. The influence of the number of fractions, overall treatment time and field size on the local control of cancer of the skin. Br J Radiol 1983; 56: 596–8
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991; 21: 163–70
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hjelm-Hansen M, Vendelbo Johansen L, Andersen A P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147–52
   PubMed Web of Science ®Google Scholar
• Peracchia G, Saki C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys 1981; 7: 99–104
   PubMed Web of Science ®Google Scholar
• Olmi P, Cellai E, Chiavacci A, Fallai C. Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother Oncol 1990; 17: 199–207
   PubMed Web of Science ®Google Scholar
• Lamb D S, Spry N A, Gray A J, Johnson A D, Alexander S R, Dally M J. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother Oncol 1990; 18: 107–16
   PubMed Web of Science ®Google Scholar
• Van der Schueren E, van den Bogaert W, Vanuytsel L, van Limbergen E. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys 1990; 19: 301–11
   PubMed Web of Science ®Google Scholar
• Van den Bogaert W, van der Schueren E, Horiot J-C, et al. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1986; 12: 587–91
   PubMedGoogle Scholar
• Wang C C, Blitzer P H, Suit H. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100–4
   PubMed Web of Science ®Google Scholar
• Wang C C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Rad Oncol Biol Phys 1988; 14: 1143–6
   PubMed Web of Science ®Google Scholar
• Ang K K, Peters L J, Webers R S, et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990; 19: 1339–45
   PubMed Web of Science ®Google Scholar
• Saunders M I, Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol 1986; 59: 523–5
   PubMedGoogle Scholar